Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Explore Cytek Biosciences’s Fair Values from the Community and select yours
Despite an already strong run, Cytek Biosciences, Inc. (NASDAQ:CTKB) shares have been powering on, with a gain of 26% in the last thirty days. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 25% over that time.
Even after such a large jump in price, Cytek Biosciences may still be sending bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 2.6x, since almost half of all companies in the Life Sciences industry in the United States have P/S ratios greater than 3.5x and even P/S higher than 6x are not unusual. However, the…
